…
Auna S.A., a healthcare service provider, operates hospitals and clinics in Mexico, Peru, and Colombia. The company provides prepaid healthcare plans; and dental and vision insurance plans. It also sells medicines. The company was founded in 1989 and is based in Luxembourg, Luxembourg.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
Auna S.A. is a Peru-based integrated healthcare operator that provides hospital, outpatient and preventive health services to individual and corporate clients. Long-term growth may be supported by demographic aging, rising private healthcare consumption and expansion of service and insurance offerings, which could support revenue diversification and margin improvement. Investors may find the company attractive for its scale in private healthcare and exposure to secular increases in health spending.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Income before tax | 187.82M | 184.52M | -124.17M | -47.45M | -3.13M |
| Minority interest | - | -13.69M | -39.58M | -8.78M | -3.45M |
| Net income | 92.01M | 110.72M | -253.92M | -85.61M | -26.47M |
| Selling general administrative | - | 788.68M | 653.67M | 477.08M | 416.78M |
| Selling and marketing expenses | - | 129.03M | 123.70M | 109.58M | 107.10M |
| Gross profit | 1568.26M | 1637.46M | 1435.35M | 879.70M | 686.93M |
| Reconciled depreciation | - | 219.15M | 235.75M | 138.09M | 77.39M |
| Ebit | 548.73M | 708.09M | 411.55M | 161.05M | 92.75M |
| Ebitda | 758.40M | 928.12M | 647.30M | 299.14M | 170.15M |
| Depreciation and amortization | 209.67M | 220.03M | 235.75M | 138.09M | 77.39M |
| Operating income | 548.73M | 708.17M | 560.34M | 254.59M | 108.14M |
| Other operating expenses | 3584.96M | 3695.63M | 3315.57M | 2197.02M | 1815.58M |
| Interest expense | 613.92M | 484.10M | 535.72M | 208.50M | 95.88M |
| Tax provision | - | 59.82M | 90.17M | 29.38M | 19.90M |
| Interest income | - | 21.09M | 16.96M | 6.88M | 1.75M |
| Net interest income | - | -508.75M | -606.50M | -208.85M | -98.40M |
| Income tax expense | 83.28M | 60.06M | 90.17M | 29.38M | 19.90M |
| Total revenue | 4133.69M | 4403.80M | 3875.91M | 2451.61M | 1923.72M |
| Total operating expenses | 1019.53M | 929.29M | 875.01M | 625.12M | 578.79M |
| Cost of revenue | 2565.43M | 2766.34M | 2440.56M | 1571.90M | 1236.78M |
| Total other income expense net | -360.91M | -523.66M | -684.51M | -302.03M | -111.27M |
| Net income from continuing ops | - | 123.96M | -214.34M | -76.83M | -23.02M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Total assets | 7297.41M | 7080.72M | 7689.55M | 6593.66M | 2823.65M |
| Intangible assets | - | 902.60M | 1059.95M | 953.03M | 325.03M |
| Other current assets | 258.49M | 262.25M | 223.45M | 324.66M | 118.68M |
| Total liab | 5531.21M | 5457.78M | 5912.99M | 5035.60M | 2277.74M |
| Total stockholder equity | 1600.62M | 1477.22M | 1465.29M | 1064.98M | 495.82M |
| Other current liab | 267.95M | 226.83M | 385.35M | 227.26M | 179.18M |
| Common stock | 17.39M | 17.39M | 8.82M | 236.55M | 236.55M |
| Capital stock | - | 17.39M | 8.82M | 236.55M | 236.55M |
| Retained earnings | 414.50M | -273.53M | -366.90M | -90.98M | -45.49M |
| Good will | 2704.11M | 1754.29M | 2069.24M | 1805.89M | 184.96M |
| Other assets | 0.00M | - | -5612.75M | - | 0.00M |
| Cash | 335.41M | 235.75M | 241.13M | 208.69M | 138.77M |
| Total current liabilities | 1666.94M | 1945.28M | 1689.31M | 2845.12M | 698.49M |
| Current deferred revenue | 0.10M | - | 40.12M | 12.01M | 0.33M |
| Net debt | 3320.29M | 3531.92M | 3678.49M | 3302.88M | 1354.26M |
| Short term debt | 345.59M | 686.69M | 417.17M | 2069.06M | 46.61M |
| Short long term debt | - | 654.23M | 385.30M | 2040.98M | 29.73M |
| Short long term debt total | 3655.70M | 3767.66M | 3919.63M | 3511.57M | 1493.03M |
| Other stockholder equity | 1209.61M | 1208.59M | - | 386.05M | 386.05M |
| Total current assets | 1844.39M | 1703.87M | 1549.15M | 1195.10M | 671.27M |
| Long term investments | - | 25.69M | 20.87M | 13.10M | 14.29M |
| Short term investments | 30.23M | 100.23M | 93.13M | 0.00M | 0.00M |
| Net receivables | 1055.48M | 961.89M | 860.92M | 574.17M | 352.66M |
| Long term debt | - | 2965.54M | 3376.28M | 1307.67M | 1322.71M |
| Inventory | 164.78M | 143.76M | 130.52M | 87.58M | 61.15M |
| Accounts payable | 1053.30M | 931.26M | 749.35M | 512.59M | 454.10M |
| Accumulated other comprehensive income | -40.88M | 524.78M | 1823.36M | 533.37M | -81.28M |
| Non currrent assets other | 26.91M | 89.57M | 110.44M | 39.88M | 163.41M |
| Non current assets total | 5453.02M | 5376.85M | 6140.40M | 5398.57M | 2152.38M |
| Capital lease obligations | - | 147.89M | 158.04M | 162.92M | 140.58M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Investments | - | -236.82M | -173.15M | -3209.44M | -291.99M |
| Total cashflows from investing activities | -78.83M | -236.82M | - | - | - |
| Net borrowings | - | 68.27M | - | - | - |
| Total cash from financing activities | -74.31M | -418.12M | -370.00M | 3130.65M | -102.13M |
| Net income | 92.01M | 123.96M | -214.34M | -76.83M | -23.02M |
| Change in cash | 124.43M | -5.39M | 32.44M | 69.92M | -204.68M |
| Begin period cash flow | 210.98M | 241.13M | 208.69M | 138.77M | 343.45M |
| End period cash flow | 335.41M | 235.75M | 241.13M | 208.69M | 138.77M |
| Total cash from operating activities | 242.83M | 668.50M | 582.41M | 162.64M | 183.34M |
| Issuance of capital stock | - | 1267.79M | - | - | - |
| Depreciation | 209.67M | 219.15M | 235.75M | 138.09M | 77.39M |
| Other cashflows from investing activities | -19.93M | -98.79M | - | - | - |
| Dividends paid | - | 1.15M | 6.84M | 0.13M | 0.00M |
| Change to inventory | -16.82M | -25.85M | -30.11M | -22.91M | -10.78M |
| Change to account receivables | -76.95M | -343.15M | -316.00M | -80.48M | -39.47M |
| Other cashflows from financing activities | -145.14M | -1753.03M | -671.18M | 1217.84M | -105.21M |
| Capital expenditures | 81.08M | 90.86M | 165.16M | 151.97M | 289.37M |
| Change in working capital | -49.07M | -172.57M | -141.63M | -174.45M | 49.03M |
| Stock based compensation | - | 9.14M | 3.67M | 0.00M | 0.00M |
| Other non cash items | -9.78M | 429.00M | 608.79M | 246.45M | 60.05M |
| Free cash flow | 161.76M | 577.64M | 417.25M | 10.67M | -106.03M |
Sector: Healthcare Industry: Medical Care Facilities
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| AUNA Auna S.A. |
- -% |
4.77 | 14.24 | - | 0.09 | 0.81 | 1.08 | 4.41 |
| HCA HCA Healthcare, Inc. |
-11.35 2.22% |
500.43 | 14.27 | 13.46 | 1.21 | 291.34 | 1.83 | 8.99 |
| THC Tenet Healthcare Corporation |
- -% |
282.07 | 10.08 | 12.66 | 0.96 | 4.57 | 1.43 | 5.80 |
| FSNUY Fresenius SE & Co KGaA ADR |
-0.01 0.07% |
14.78 | 16.87 | 9.44 | 0.42 | 0.78 | 0.79 | 5.37 |
| JDHIY JD Health International Inc |
- -% |
5.57 | 62.50 | 35.97 | 0.30 | 2.32 | 0.16 | 3.90 |
Auna S.A., a healthcare service provider, operates hospitals and clinics in Mexico, Peru, and Colombia. The company provides prepaid healthcare plans; and dental and vision insurance plans. It also sells medicines. The company was founded in 1989 and is based in Luxembourg, Luxembourg.
| Name | Title | Year Born |
|---|---|---|
| Mr. Jesús Zamora Leon | President, CEO & Executive Chairman of the Board | 1963 |
| Ms. Gisele Remy Ferrero | CFO & Executive VP | NA |
| Mr. Marco Roca | Executive VP of Regional Operations & Country Representative of Peru | NA |
| Mr. Andres Angel | Executive VP of AunaWay implementation & Country Representative in Colombia | NA |
| Mr. Sven Boes | Executive VP of Regional Healthcare Services & Country Representative of Mexico | NA |
| Mr. Laurent Massart | Executive VP of Strategy & Equity Capital Markets | NA |
| Mr. Jesús Antonio Zamora Leon | President, CEO & Executive Chairman of the Board | 1964 |
| Ms. Gisele Remy Ferrero | CFO & Executive VP | 1980 |
| Ms. Rayet Harb | Executive Vice President Operations | 1973 |
| Mr. Laurent Massart | Executive VP of Strategy & Equity Capital Markets | 1968 |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.